The current treatment of choice in patients with advanced or metastatic squamous-cell carcinoma (SCC) of the skin is immunotherapy based on anti-PD1/L1 antibodies. For many years, there has been a consensus, that SCC of the skin is a chemorefractory neoplasm. However, despite a recent approval of checkpoint inhibitors for the treatment of cutaneous SCC, their extremely high cost makes them unavailable for many patients worldwide, and additionally, in many patients, their use may be contraindicated by patients’ clinical conditions. This article provides strong arguments that optimized and well-matched chemotherapy still represents an active treatment option even in the era of novel therapies.
Despite the overall excellent survival rates in patients affected by early cutaneous squamous cell c...
Cutaneous squamous cell carcinoma (CSCC) accounts for approximately 20% of all keratinocytic tumors....
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer, the incidenc...
The current treatment of choice in patients with advanced or metastatic squamous-cell carcinoma (SCC...
Squamous cell carcinoma (SCC) has the second highest incidence rate among non-melanoma skin cancers....
Squamous cell carcinoma of the skin (SCCS) is a common malignancy with potentially devastating conse...
There are few randomized controlled studies to guide the treatment of advanced cutaneous squamous ce...
Squamous cell carcinoma of the skin (SCCS) is a common malignancy with potentially devastating conse...
11Cutaneous squamous cell carcinoma (cSCC) is the second most frequent nonmelanoma skin cancer (NMSC...
Squamous cell carcinoma of the skin, or cutaneous squamous cell carcinoma (CSCC), is the second most...
Immunosuppression, both iatrogenic and disease-related, is associated with a greatly increased incid...
© 2021 by the authors.Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in...
Cutaneous squamous cell carcinoma (cSCC) is a common malignancy of the skin and has an overall favor...
BACKGROUNDNo systemic therapies have been approved for the treatment of advanced cutaneous squamous-...
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent type of non-melanoma skin cance...
Despite the overall excellent survival rates in patients affected by early cutaneous squamous cell c...
Cutaneous squamous cell carcinoma (CSCC) accounts for approximately 20% of all keratinocytic tumors....
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer, the incidenc...
The current treatment of choice in patients with advanced or metastatic squamous-cell carcinoma (SCC...
Squamous cell carcinoma (SCC) has the second highest incidence rate among non-melanoma skin cancers....
Squamous cell carcinoma of the skin (SCCS) is a common malignancy with potentially devastating conse...
There are few randomized controlled studies to guide the treatment of advanced cutaneous squamous ce...
Squamous cell carcinoma of the skin (SCCS) is a common malignancy with potentially devastating conse...
11Cutaneous squamous cell carcinoma (cSCC) is the second most frequent nonmelanoma skin cancer (NMSC...
Squamous cell carcinoma of the skin, or cutaneous squamous cell carcinoma (CSCC), is the second most...
Immunosuppression, both iatrogenic and disease-related, is associated with a greatly increased incid...
© 2021 by the authors.Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in...
Cutaneous squamous cell carcinoma (cSCC) is a common malignancy of the skin and has an overall favor...
BACKGROUNDNo systemic therapies have been approved for the treatment of advanced cutaneous squamous-...
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent type of non-melanoma skin cance...
Despite the overall excellent survival rates in patients affected by early cutaneous squamous cell c...
Cutaneous squamous cell carcinoma (CSCC) accounts for approximately 20% of all keratinocytic tumors....
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer, the incidenc...